8
Live / Registered — Registered (as of 15 Apr 2025)
What this means for you
Registered since 15 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90785551
- Registration number
- 7762644
- Mark type
- Design + words
- Filed
- 21 Jun 2021
- Published for opposition
- 02 Nov 2021
- Registered
- 15 Apr 2025
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, oncological preparations; reagent, diagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression
- Class 042 — Scientific and technological services: research, development, and evaluation of new products; pharmaceutical, medicine, and vaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology
- Class 045 — Legal and security services: development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment
Owner
- IN8bio, Inc., New York, NY, US
- IN8bio, Inc., New York, NY, US
- IN8bio, Inc., New York, NY, US
Prosecution history
- 15 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Dec 2024 — USE AMENDMENT FILED
- 07 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 21 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2024 — SOU EXTENSION 5 GRANTED
- 21 Jun 2024 — SOU EXTENSION 5 FILED
- 21 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2023 — SOU EXTENSION 4 GRANTED
- 15 Dec 2023 — SOU EXTENSION 4 FILED